[Participation of gastroduodenal mucosa prostaglandins in the anti-ulcer effect of venter].
R A
RA
Vysotskaia
A S
AS
Loginov
Iu V
IuV
Vasil'ev
A A
AA
Il'chenko
O I
OI
Pechkovskaia
E A
EA
Bendikov
D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D015237:Dinoprost / Q000096:biosynthesis; D004381:Duodenal Ulcer / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D004386:Duodenum / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D011453:Prostaglandins / Q000096:biosynthesis*; D011458:Prostaglandins E / Q000096:biosynthesis; D013392:Sucralfate / Q000494:pharmacology*
D000897:Anti-Ulcer Agents; D011453:Prostaglandins; D011458:Prostaglandins E; D013392:Sucralfate; D015237:Dinoprost
Uchastie prostaglandinov gastroduodenal'noĭ slizistoĭ obolochki v mekhanizme deĭstviia protivoiazvennogo preparata venter.